These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 25138639)

  • 1. The retrovirus/superantigen hypothesis of multiple sclerosis.
    Emmer A; Staege MS; Kornhuber ME
    Cell Mol Neurobiol; 2014 Nov; 34(8):1087-96. PubMed ID: 25138639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human endogenous retrovirus-K18 Env as a risk factor in multiple sclerosis.
    Tai AK; O'Reilly EJ; Alroy KA; Simon KC; Munger KL; Huber BT; Ascherio A
    Mult Scler; 2008 Nov; 14(9):1175-80. PubMed ID: 18701576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of immune responses against multiple sclerosis-associated retrovirus/human endogenous retrovirus W in patients with multiple sclerosis.
    Ruprecht K; Gronen F; Sauter M; Best B; Rieckmann P; Mueller-Lantzsch N
    J Neurovirol; 2008 Apr; 14(2):143-51. PubMed ID: 18444086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of human endogenous retrovirus HERV-K18 superantigen is elevated in juvenile rheumatoid arthritis.
    Sicat J; Sutkowski N; Huber BT
    J Rheumatol; 2005 Sep; 32(9):1821-31. PubMed ID: 16142883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do Antiretroviral Drugs Protect From Multiple Sclerosis by Inhibiting Expression of MS-Associated Retrovirus?
    Morandi E; Tanasescu R; Tarlinton RE; Constantin-Teodosiu D; Gran B
    Front Immunol; 2018; 9():3092. PubMed ID: 30740110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-reactivity between myelin oligodendrocyte glycoprotein and human endogenous retrovirus W protein: nanotechnological evidence for the potential trigger of multiple sclerosis.
    de Luca V; Martins Higa A; Malta Romano C; Pimenta Mambrini G; Peroni LA; Trivinho-Strixino F; Lima Leite F
    Micron; 2019 May; 120():66-73. PubMed ID: 30802755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies against a human endogenous retrovirus and the preponderance of env splice variants in multiple sclerosis patients.
    Christensen T; Sørensen PD; Hansen HJ; Møller-Larsen A
    Mult Scler; 2003 Feb; 9(1):6-15. PubMed ID: 12617261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human endogenous retroviruses in the aetiology of MS.
    Christensen T
    Acta Neurol Scand; 2017 Nov; 136 Suppl 201():18-21. PubMed ID: 29068488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natalizumab modulates the humoral response against HERV-Wenv73-88 in a follow-up study of Multiple Sclerosis patients.
    Arru G; Caggiu E; Leoni S; Mameli G; Pugliatti M; Sechi GP; Sechi LA
    J Neurol Sci; 2015 Oct; 357(1-2):106-8. PubMed ID: 26190523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of Proinflammatory Multiple Sclerosis-Associated Retrovirus Envelope Protein by Human Herpesvirus-6A and CD46 Receptor Engagement.
    Charvet B; Reynaud JM; Gourru-Lesimple G; Perron H; Marche PN; Horvat B
    Front Immunol; 2018; 9():2803. PubMed ID: 30574140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retrovirus superantigen hypothesis of multiple sclerosis].
    Emmer A; Staege MS; Kornhuber ME
    Nervenarzt; 2013 Oct; 84(10):1245-6. PubMed ID: 24052080
    [No Abstract]   [Full Text] [Related]  

  • 12. B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity.
    Brudek T; Christensen T; Aagaard L; Petersen T; Hansen HJ; Møller-Larsen A
    Retrovirology; 2009 Nov; 6():104. PubMed ID: 19917105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human leukemia antigen-A*0201-restricted epitopes of human endogenous retrovirus W family envelope (HERV-W env) induce strong cytotoxic T lymphocyte responses.
    Tu X; Li S; Zhao L; Xiao R; Wang X; Zhu F
    Virol Sin; 2017 Aug; 32(4):280-289. PubMed ID: 28840564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses.
    Christensen T
    Rev Med Virol; 2005; 15(3):179-211. PubMed ID: 15782388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen.
    Sutkowski N; Conrad B; Thorley-Lawson DA; Huber BT
    Immunity; 2001 Oct; 15(4):579-89. PubMed ID: 11672540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis-associated retrovirus particles cause T lymphocyte-dependent death with brain hemorrhage in humanized SCID mice model.
    Firouzi R; Rolland A; Michel M; Jouvin-Marche E; Hauw JJ; Malcus-Vocanson C; Lazarini F; Gebuhrer L; Seigneurin JM; Touraine JL; Sanhadji K; Marche PN; Perron H
    J Neurovirol; 2003 Feb; 9(1):79-93. PubMed ID: 12587071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic immune responses induced by endogenous retrovirus and herpesvirus antigens result in increased production of inflammatory cytokines in multiple sclerosis patients.
    Brudek T; Christensen T; Hansen HJ; Petersen T; Møller-Larsen A
    Scand J Immunol; 2008 Mar; 67(3):295-303. PubMed ID: 18261041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The aliens inside us: HERV-W endogenous retroviruses and multiple sclerosis.
    Dolei A
    Mult Scler; 2018 Jan; 24(1):42-47. PubMed ID: 29307292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vbeta16 T-lymphocyte activation.
    Perron H; Jouvin-Marche E; Michel M; Ounanian-Paraz A; Camelo S; Dumon A; Jolivet-Reynaud C; Marcel F; Souillet Y; Borel E; Gebuhrer L; Santoro L; Marcel S; Seigneurin JM; Marche PN; Lafon M
    Virology; 2001 Sep; 287(2):321-32. PubMed ID: 11531410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine Vbeta3+ and Vbeta7+ T cell subsets are specific targets for the HERV-K18 Env superantigen.
    Tai AK; Lin M; Chang F; Chen G; Hsiao F; Sutkowski N; Huber BT
    J Immunol; 2006 Sep; 177(5):3178-84. PubMed ID: 16920956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.